Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

The VAI status indicates that there are no such complying issues with the facility; hence, the USFDA will not take any regulatory or administrative action against the facility.

Despite successful models in a few parts of India where regulated access to opioids has been implemented safely, there ...

Based on extensive collaboration with veterinarians, industry, food animal producers and other stakeholders, we have developed the List of Needed Veterinary Drugs. As Health Canada cannot compel drug ...

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for another ... essential medicines — those covered under the National List of Essential Medicines (NLEM ...

Types of Addictive Drugs When drugs are introduced to the system, dopamine, a neurotransmitter that responds to pleasurable activities is switched on and lights up that network. Below is a list of ...

The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the ...

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

Budget 2025: The Finance Minister also informed that the government will exempt basic custom duty on 37 more medicines. (Image Credits: FE) Budget 2025: Finance Minister Nirmala Sitharaman on ...

Agencies This update is expected to impact drug makers like Aarti Drugs, Cipla, Abbott India, Ajanta Pharma, Alkem Labs, AstraZeneca, Biocon, Lupin, and Dr. Lal Path Labs. Sitharaman stated that the ...

All eyes were on what gets cheaper and what gets expensive as the Finance Minister announced major customs duty changes on several products from cancer drugs to wet blue leather ... two more types of ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements.